Psychotropic Medication and Psychotropic Polypharmacy Among Children and Adolescents in the US Child Welfare System
- PMID: 37603358
- PMCID: PMC10442784
- DOI: 10.1001/jamapediatrics.2023.3068
Psychotropic Medication and Psychotropic Polypharmacy Among Children and Adolescents in the US Child Welfare System
Plain language summary
This cross-sectional study evaluates rates of psychotropic medication and polypharmacy use among youths in the US child welfare system compared with other youths with Medicaid coverage in 2019.
Conflict of interest statement
Figures
Comment in
-
Child Welfare Youth-Psychotropic Use and Implications.JAMA Pediatr. 2024 Jan 1;178(1):99. doi: 10.1001/jamapediatrics.2023.5252. JAMA Pediatr. 2024. PMID: 38010702 No abstract available.
References
-
- American Academy of Child and Adolescent Psychiatry . Recommendations for the use of psychotropic medications for children and youth involved in child serving systems. Accessed May 29, 2023. https://www.aacap.org/App_Themes/AACAP/docs/clinical_practice_center/sys...
-
- Government Accountability Office . 2017. Foster care: HHS has taken steps to support states’ oversight of psychotropic medications, but additional assistance could further collaboration. Accessed May 29, 2023. https://www.gao.gov/assets/gao-17-129.pdf
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
